CognomIQ is selectively identifying Board Level executives as it enters its next phase of national expansion. Most health systems are paying for 25 or more fragmented SaaS tools that still cannot deliver a singular, trusted view of their data. CognomIQ replaces all of them in a single, entirely proprietary platform built by healthcare, for healthcare. No outside AI or LLMs. No AWS or Azure dependency. No pass-through costs. On-premise or private cloud. SOC2, HIPAA, HL7, and FHIR compliant. You own your data. We do not copy, share, or sell it. One platform displaces Snowflake, Databricks, PowerBI, Tableau, Flatiron, HealthCatalyst, Tempus, Deep6 AI, Denodo, Datavant, Amazon Redshift, ESRI, Paradigm Health, TriNetX, Availity, and more. Custom data interfaces built in days not months. Custom semantic translation that surpasses OMOP. The proof is in a live demo. This performance cannot be faked. In four years of full production, the platform has Powered 100+ peer-reviewed oncology and clinical publications Helped University of Rochester's Wilmot Cancer Center win NCI designation #73, unlocking $35M in federal funding Ingests hundreds of live data feeds, validating and harmonizing to deliver the highest accuracy results in healthcare Delivered 7-figure annual savings per institution through SaaS consolidation Accelerated research, trials, and operational workflow by 15X or more. Months become minutes, days become seconds Required only 1 to 2 FTEs to manage. No large IT team, no interface programmers, no manual ETL Recognized with the Gold and Silver Digital Health Awards (2024/2023), Prix Galien Runner-Up 2024, and Cancer Moonshot alignment. One acquisition offer has already been declined. This engagement is tied to the current Preferred Equity round and is designed for individuals who Have led enterprise healthcare or data transformation Operate at governance or Board Level Understand healthcare research economics and long procurement cycles Recognize infrastructure-layer platforms before mainstream adoption Participation is structured for senior-level involvement only. Qualified executives will receive additional information following review.